Back to Market Feed

LAMOTRIGINE ER 50 MG TABLET

lamotrigine extended release
$0.6273per EA

Strength

50 mg/1

Manufacturer

Endo USA Inc.

NDC

49884056211

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LAMOTRIGINE

Approval Type

Generic (ANDA)

FDA Application

ANDA201791

On Market Since

1/18/2013

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price History

1W

0.0%

1M

-0.2%

3M

-10.3%

6M

-9.2%

1Y

-14.1%

3Y

-37.6%

5Y

-68.6%

All

-92.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

GABAPENTIN 100 MG CAPSULE
Generic
00480349405•Teva Pharmaceuticals USA Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
00904666561•Major Pharmaceuticals
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086701•Rising Pharma Holdings Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086710•Rising Pharma Holdings Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086750•Rising Pharma Holdings Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16714066101•NorthStar Rx LLC
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16714066102•NorthStar Rx LLC
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
23155086601•Heritage Pharmaceuticals Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
23155086605•Heritage Pharmaceuticals Inc.
$0.0211
per EA
GABAPENTIN 100 MG CAPSULE
Generic
31722014801•Camber Pharmaceuticals Inc.
$0.0211
per EA